KISNER DANIEL L
Insider CIK 1073407 · DVAX Director · LPTN Director · ONCT Director · CNAT Director · TKMR · ZYNE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 15,000 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 25,000 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 28,500 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 22,500 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 22,500 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 25,000 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 22,500 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer | 2026-02-10 | 2026-02-10 | 21,829 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | U Tender | 2026-02-10 | 2026-02-10 | 1,500 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2025-06-11 | 2025-06-13 | 28,500 | — | $0 | 28,500 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award | 2025-06-11 | 2025-06-13 | 5,758 | — | $0 | 23,329 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2024-06-20 | 2024-06-24 | 2,200 | — | $0 | 2,200 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2024-05-23 | 2024-05-28 | 22,500 | — | $0 | 22,500 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award | 2024-05-23 | 2024-05-28 | 5,357 | — | $0 | 17,571 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | D To issuer deriv | 2023-10-10 | 2023-10-11 | 34,663 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | D To issuer deriv | 2023-10-10 | 2023-10-11 | 71,736 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | U Tender | 2023-10-10 | 2023-10-11 | 47,824 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | U Tender | 2023-10-10 | 2023-10-11 | 27,954 | — | $0 | 47,824 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-06-28 | 2023-06-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| HSTO Histogen Inc. | A Award deriv | 2023-06-20 | 2023-06-21 | 6,835 | — | $0 | 6,835 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | S Sale | 2023-06-14 | 2023-06-15 | 115 | $0.35 | $40 | 75,778 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2023-06-13 | 2023-06-15 | 71,736 | — | $0 | 71,736 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-06-13 | 2023-06-15 | 47,824 | — | $0 | 75,893 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2023-05-26 | 2023-05-31 | 22,500 | — | $0 | 22,500 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award | 2023-05-26 | 2023-05-31 | 5,357 | — | $0 | 12,214 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2022-06-16 | 2022-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2022-06-14 | 2022-06-16 | 34,663 | — | $0 | 34,663 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2022-06-14 | 2022-06-16 | 23,109 | — | $0 | 28,109 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | S Sale | 2022-06-14 | 2022-06-16 | 40 | $1.01 | $40 | 28,069 | SEC↗ |
| HSTO Histogen Inc. | A Award deriv | 2022-06-01 | 2022-06-03 | 1,000 | — | $0 | 1,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2022-05-26 | 2022-05-27 | 22,500 | — | $0 | 22,500 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2022-05-26 | 2022-05-27 | 5,357 | — | $0 | 5,357 | SEC↗ |
| HSTO Histogen Inc. | A Award deriv | 2021-09-02 | 2021-09-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2021-08-03 | 2021-08-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2021-08-03 | 2021-08-05 | 5,000 | — | $0 | 5,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2021-05-28 | 2021-06-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2021-05-25 | 2021-05-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| HSTO Histogen Inc. | A Award deriv | 2020-10-07 | 2020-10-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2020-07-21 | 2020-07-23 | 5,000 | $2.38 | $11.9K | 5,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2020-07-21 | 2020-07-23 | 10,000 | $2.38 | $23.8K | 10,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2020-06-11 | 2020-07-31 | 15,000 | — | $0 | 30,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2020-06-11 | 2020-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2020-06-10 | 2020-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2020-05-28 | 2020-05-29 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2019-09-12 | 2020-07-31 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2019-09-12 | 2019-09-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2019-06-27 | 2019-07-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2019-06-11 | 2019-06-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2019-05-30 | 2019-05-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2018-06-21 | 2018-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2018-06-06 | 2018-06-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2018-05-31 | 2018-06-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2017-06-22 | 2017-06-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2017-06-07 | 2017-06-09 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2017-06-02 | 2017-06-02 | 7,500 | — | $0 | 7,500 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | J Other | 2016-12-28 | 2016-12-30 | 2,310 | — | $0 | 5,455 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2016-06-23 | 2016-06-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2016-05-31 | 2016-05-31 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2016-05-25 | 2016-07-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LPTN LPATH, INC | A Award deriv | 2016-02-16 | 2016-02-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2015-10-13 | 2015-10-14 | 13,200 | — | $0 | 13,200 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2015-08-04 | 2015-08-06 | 35,000 | — | $0 | 35,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2015-06-11 | 2015-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2015-05-27 | 2015-05-28 | 7,500 | — | $0 | 7,500 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | P Buy | 2015-04-08 | 2015-04-10 | 4,000 | $5.75 | $23.0K | 7,145 | SEC↗ |
| LPTN LPATH, INC | A Award deriv | 2015-02-10 | 2015-02-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2014-05-28 | 2014-05-29 | 17,500 | — | $0 | 17,500 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | J Other | 2014-02-19 | 2016-12-30 | 3,145 | — | $0 | 3,145 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | J Other | 2014-02-19 | 2014-02-25 | 3,145 | — | $0 | 3,145 | SEC↗ |
| LPTN LPATH, INC | A Award deriv | 2014-02-10 | 2014-02-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2014-02-07 | 2014-02-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | P Buy | 2013-10-30 | 2013-10-30 | 10,000 | $1.08 | $10.8K | 15,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2013-05-29 | 2013-06-05 | 17,500 | — | $0 | 17,500 | SEC↗ |
| LPTN LPATH, INC | A Award deriv | 2013-01-29 | 2013-01-31 | 6,012 | — | $0 | 6,012 | SEC↗ |
| LPTN LPATH, INC | A Award | 2012-07-30 | 2012-08-01 | 70,590 | — | $0 | 70,590 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2012-05-30 | 2012-05-31 | 17,500 | — | $0 | 17,500 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2012-03-09 | 2012-03-12 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2012-01-26 | 2012-01-27 | 5,000 | — | $0 | 15,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2012-01-26 | 2012-01-27 | 5,000 | $2.02 | $10.1K | 5,000 | SEC↗ |